Viewing Study NCT03728361


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2026-02-26 @ 6:53 AM
Study NCT ID: NCT03728361
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-18
First Post: 2018-10-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer
Sponsor: Dwight Owen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module